Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. junior Avg
|
|
New words:
batch, behalf, Certification, checkpoint, compromise, confidential, discovering, document, duly, earlier, Exhibit, exposure, formatted, herewith, Inline, Instance, Interactive, Linkbase, omitted, Page, President, registrant, reputation, Schema, Scott, sector, Senior, sooner, Spitznagel, thereunto, undersigned, Vice, XBRL
Removed:
accelerated, accounted, ADC, Additionally, adjust, amortize, assumed, August, autoimmune, bankruptcy, Biopharma, blockade, breach, calculate, canceled, candidate, challenged, China, comprehensive, constituted, contingent, coordinate, creditable, criteria, decided, deemed, delivery, diagnosed, discontinue, earned, encompassing, enrolling, equal, evaluating, event, external, Fc, February, foreign, greater, hematological, Hong, immaterial, informed, judgment, June, Kong, liability, life, LLC, Macau, mainland, measure, met, modulate, netting, newly, Note, occurrence, Optimization, outset, outstanding, par, partial, participant, participate, party, percentage, periodically, point, premium, prospective, purpose, range, reassessed, recession, referred, regional, reimbursement, relevant, renamed, repayment, represented, representing, repurchased, response, Sanofi, satisfying, significantly, smaller, solid, split, subsequently, subsidiary, surrendered, Taiwan, territory, threshold, tied, title, TRIDENT, Trust, unamortized, undisclosed, United, validity, warrant
Filing tables
Filing exhibits
Associated MGNX transcripts
MGNX similar filings
Filing view
External links
EXHIBIT 32.2
Certification of Principal Financial Officer
Pursuant to 18 U.S.C. 1350
(Section 906 of the Sarbanes-Oxley Act of 2002)
I, James Karrels, Senior Vice President and Chief Financial Officer (principal financial officer) of MacroGenics, Inc. (the Registrant), certify, to the best of my knowledge, based upon a review of the Quarterly Report on Form 10-Q for the period ended March 31, 2024 of the Registrant (the Report), that:
1.The Report fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934, as amended; and
2.The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.
/s/ James Karrels
Name: James Karrels
Date: May 9, 2024